Global Medical REIT Inc (GMRE) Given Consensus Recommendation of “Buy” by Brokerages

Global Medical REIT Inc (NYSE:GMRE) has been assigned an average rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $10.51.

Several brokerages have recently commented on GMRE. Stifel Nicolaus began coverage on shares of Global Medical REIT in a research report on Monday, April 15th. They set a “buy” rating and a $11.00 price target for the company. Zacks Investment Research cut shares of Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th. B. Riley set a $11.00 price target on shares of Global Medical REIT and gave the stock a “buy” rating in a research report on Friday, March 8th. Finally, Boenning Scattergood reiterated a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th.

Shares of NYSE:GMRE traded up $0.29 during trading on Tuesday, hitting $10.09. 456,940 shares of the company’s stock were exchanged, compared to its average volume of 382,265. Global Medical REIT has a 1-year low of $7.55 and a 1-year high of $11.02. The company has a debt-to-equity ratio of 1.25, a current ratio of 0.11 and a quick ratio of 0.11. The stock has a market cap of $265.60 million, a price-to-earnings ratio of 12.94, a P/E/G ratio of 1.35 and a beta of 0.61.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Thursday, March 7th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.21 by $0.10. Global Medical REIT had a net margin of 22.62% and a return on equity of 6.29%. The company had revenue of $14.38 million during the quarter, compared to analysts’ expectations of $14.46 million. Equities research analysts anticipate that Global Medical REIT will post 0.83 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 10th. Investors of record on Tuesday, March 26th were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 7.93%. The ex-dividend date was Monday, March 25th. Global Medical REIT’s dividend payout ratio is currently 102.56%.

In related news, Director Roscoe M. Moore, Jr. sold 5,945 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $9.75, for a total transaction of $57,963.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 13.00% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Strs Ohio grew its holdings in Global Medical REIT by 9.0% during the first quarter. Strs Ohio now owns 35,497 shares of the company’s stock valued at $348,000 after purchasing an additional 2,923 shares during the period. Nisa Investment Advisors LLC acquired a new position in Global Medical REIT during the first quarter valued at approximately $85,000. Financial Advantage Inc. acquired a new position in Global Medical REIT during the first quarter valued at approximately $31,000. RMR Advisors LLC grew its holdings in Global Medical REIT by 13.1% during the first quarter. RMR Advisors LLC now owns 495,467 shares of the company’s stock valued at $4,865,000 after purchasing an additional 57,500 shares during the period. Finally, State of Alaska Department of Revenue grew its holdings in Global Medical REIT by 19.9% during the first quarter. State of Alaska Department of Revenue now owns 7,412 shares of the company’s stock valued at $72,000 after purchasing an additional 1,229 shares during the period. Hedge funds and other institutional investors own 41.76% of the company’s stock.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More: Why do companies pay special dividends?

Analyst Recommendations for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.